您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览40

We evaluated the feasibility of planning stereotactic body radiotherapy (SBRT) for large central early-stage non-small cell lung cancer with a tri-cobalt-60 (tri-(60)Co) system equipped with real-time magnetic resonance imaging (MRI) guidance, as compared to linear accelerator (LINAC)-based SBRT. In all, 20 patients with large central early-stage non-small cell lung cancer who were treated between 2010 and 2015 with LINAC-based SBRT were replanned using a tri-(60)Co system for a prescription dose of 50Gy in 4 fractions. Doses to organs at risk were evaluated based on established MD Anderson constraints for central lung SBRT. R100 values were calculated as the total tissue volume receiving 100

作者:Catherine, Merna;Jean-Claude M, Rwigema;Minsong, Cao;Pin-Chieh, Wang;Amar U, Kishan;Argin, Michailian;James, Lamb;Ke, Sheng;Nzhde, Agazaryan;Daniel A, Low;Patrick, Kupelian;Michael L, Steinberg;Percy, Lee

来源:Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2016 年 41卷 1期

相似文献
知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:40
作者:
Catherine, Merna;Jean-Claude M, Rwigema;Minsong, Cao;Pin-Chieh, Wang;Amar U, Kishan;Argin, Michailian;James, Lamb;Ke, Sheng;Nzhde, Agazaryan;Daniel A, Low;Patrick, Kupelian;Michael L, Steinberg;Percy, Lee
来源:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2016 年 41卷 1期
标签:
Early-stage lung cancer MRI-guided radiotherapy SBRT ViewRay non?small cell lung cancer
We evaluated the feasibility of planning stereotactic body radiotherapy (SBRT) for large central early-stage non-small cell lung cancer with a tri-cobalt-60 (tri-(60)Co) system equipped with real-time magnetic resonance imaging (MRI) guidance, as compared to linear accelerator (LINAC)-based SBRT. In all, 20 patients with large central early-stage non-small cell lung cancer who were treated between 2010 and 2015 with LINAC-based SBRT were replanned using a tri-(60)Co system for a prescription dose of 50Gy in 4 fractions. Doses to organs at risk were evaluated based on established MD Anderson constraints for central lung SBRT. R100 values were calculated as the total tissue volume receiving 100